Wancheng Gene

About:

Wancheng Gene is a single-cell gene detection platform that uses the platform to serve the scientific, clinical and industrial markets.

Website: http://www.10kgenomics.com/

Top Investors: Northern Light Venture Capital, CD Capital, Empower Investment, Qiandao Fund

Description:

Wancheng Gene is a single-cell gene detection platform, which is mainly used to serve the scientific research, clinical and industrial markets with a self-developed high-throughput single-cell sequencing technology platform. The existing services of Wancheng Gene include sample preparation, database sequencing, analysis, and sample processing. They can be freely combined according to customer needs, and provide peripheral services such as sample preparation training and biometric analysis.

Total Funding Amount:

105M CNY

Headquarters Location:

Shanghai, Shanghai, China

Founded Date:

2018-02-01

Contact Email:

techsupport(AT)10kgenomics.com

Founders:

Weiyang Shi

Number of Employees:

11-50

Last Funding Date:

2021-12-30

IPO Status:

Private

Industries:

© 2025 bioDAO.ai